射波刀放射外科治疗残留或复发1级脉络丛乳头状瘤:单机构经验
该单机构回顾性研究纳入2005至2022年接受立体定向放射外科(SRS)治疗的3例成人残留或复发1级脉络丛乳头状瘤患者共5个病灶,中位年龄63岁,中位随访26个月;病灶局部控制率为80%,无放射性不良事件,无患者需后续手术。
要点
- 3例成人残留或复发1级脉络丛乳头状瘤患者共5个病灶接受SRS,中位随访26个月。
- 病灶局部控制率为80%,1例出现SRS野外新病灶,1个病灶进展但无需后续治疗。
- 无患者出现放射相关不良事件,无患者SRS后需手术治疗。
核心结论
- 作者认为,在本病例系列中SRS治疗复发或残留脉络丛乳头状瘤是安全有效的治疗方式。
- 作者鼓励开展更大规模研究以验证SRS在复发或残留脉络丛乳头状瘤治疗中的作用。
研究设计与样本
- 单机构回顾性病例系列,纳入2005至2022年在该院接受SRS治疗的组织病理学确诊的成人残留或复发脉络丛乳头状瘤患者。
- 共识别3例患者、5个病灶,中位年龄63岁;4个病灶单次分割治疗,1例患者3次分割治疗;中位随访26个月。
主要发现
- 病灶局部肿瘤控制率为80%。
- 1例患者出现SRS野外新病灶,1个病灶进展但无需后续治疗。
- 影像学上病灶无显著缩小。
- 无患者出现放射相关不良事件,无患者SRS后在该院需手术治疗。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文指出,由于该病罕见,成人残留或复发脉络丛乳头状瘤SRS治疗的循证依据仍缺乏。
- 作者鼓励开展更大规模研究以验证SRS在该病治疗中的作用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Choroid plexus papillomas (CPPs) are rare intraventricular brain tumors derived from the epithelium of the choroid plexus. Gross total resection has traditionally been considered curative, but residual tumor or recurrence remains possible. Stereotactic radiosurgery (SRS) has become a more important strategy for subtotally resected and recurrent tumors. The evidence-based rationale of SRS treatment for residual or recurrent CPP in adult patients is still lacking because of the rarity of the disease. METHODS: We retrospectively reviewed the cases of histopathologically confirmed patients with residual or recurrent CPP treated with SRS at our institute in the adult population between 2005 and 2022. Three patients, with 5 lesions, were identified, with a median age of 63 years. Patients presented initially with hydrocephalus-related symptoms, although ventriculomegaly was noted in only 1 patient radiographically. The tumor location was most commonly in the fourth ventricle or along the foramen of Luschka. Treatment was delivered in a single fraction in 4 lesions and in 3 fractions in 1 patient. The median follow-up was 26 months. RESULTS: The local tumor control rate for the lesions was 80%. One patient developed a new lesion outside the SRS field, and 1 lesion developed progression without the need for subsequent treatment. There was no significant shrinkage of the lesions radiographically. None of the patients showed radiation-related adverse events. No patients required surgical management after SRS treatment at our institution. Based on the literature review, our case series was the second largest retrospective series from a single institution on SRS for recurrent or residual CPP. CONCLUSIONS: SRS for patients with recurrent or residual CPP was a safe and effective treatment modality in this case series. Larger studies are encouraged to validate the role of SRS in the treatment of recurrent or residual CPP.
引用
- Zhang M, Park DJ, Marianayagam NJ, et al. CyberKnife Radiosurgery for Treatment of Residual or Recurrent Grade 1 Choroid Plexus Papilloma: A Single-Institution Experience. World Neurosurg. 2023. PMID: 37423336. doi:10.1016/j.wneu.2023.07.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。